We also observed an enrichment of NER genes in the PR group, which is in agreement with previous data relating high expression of NER genes to platinum resistance in ovarian carcinoma, as platinum‐DNA adducts are resolved by NER mechanisms.48 This evidence concerns the gene NR1H2 and ovarian carcinoma.